Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Value-Based Care Continues to Evolve in Rheumatology

Vanessa Caceres  |  April 24, 2023

Value-Based Care

Drs Edgerton, Worthing and Hausmann addressed the roots of value-based care, including the use of the Sustainable Growth Rate (SGR), a formula for controling physician payment in the late 1990s that later failed.

After the SGR’s failure to rein in costs, “There was a big discrepancy between what the budget formula was going to be to pay for medical care and what the reality of increasing costs were,” Dr. Worthing says. “Congress constantly needed to find the money to plug the gap. The doctors and hospitals would continually lobby Congress to close that gap in order to keep the system going.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

That situation led to the development of the Merit-Based Incentive Payment System (MIPS), which is a modified value-based, fee-for-service system; or joining an alternative payment model (APM).

At Dr. Worthing’s clinic, patients are seen on a fee-for-service system, and Medicare patients are seen as part of MIPS. “We’re trying to make sure that what we do has value as that system defines it, making sure we have quantified rheumatoid arthritis [RA] disease activity,” Dr. Worthing says. This approach includes performing a Clinical Disease Activity Index and tracking and documenting osteoporosis screenings, among other things.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Edgerton shared his experience working with a value-based contract with the clinic’s major commercial insurer. “For patients with [RA], we have sort of an algorithmic pathway that’s laid out by which we ensure that we measure disease activity and track the use of different medications based on those disease activity scores so that decisions are made according to what the patient really needs,” he says.

Drs Edgerton and Worthing also addressed how they manage external costs under a value-based care model. Example: What happens to costs if a patient is sent for an MRI?

“You have to make sure that you’re not trying to control costs that really aren’t attributed to your care,” Dr. Edgerton says, pointing out that costs in RA are usually related to medication use. “What we’ve tried to avoid and done successfully with this contract is being held accountable for things like an emergency room visit.”

Get Involved

Rheumatologists have multiple options to become more involved with government affairs and initiatives related toward value-based care, according to Dr. Edgerton and Worthing. They can use the ACR’s RISE Registry to submit measures that need to be sent to Medicare.

Also, the ACR’s Legislative Action Center enables rheumatologists to stay current on advocacy efforts led by the ACR, Dr. Edgerton says. Through the Action Center, physicians can take part in federal campaigns and email pre-written letters to Congress. Examples: The ACR is currently conducting a campaign urging the Senate to modernize prior authorization in Medicare Advantage plans. Some other efforts to advocate for legislative solutions include such issues as workforce shortages, step therapy protocols, pharmacy benefit manager transparency and more.

Page: 1 2 3 | Single Page
Share: 

Filed under:Practice Support Tagged with:ACR on AirACR on Air podcastcostsvalue-based care

Related Articles

    ACR in Action: A Look at ACR Activities That Support Your Practice

    February 1, 2018

    Rheumatologists working in every practice setting face a number of challenges that can seem insurmountable. How do you cost-effectively manage administrative burdens? How do you establish an efficient and effective approach to capturing quality metrics? How do you maintain the critical elements of the care you provide, such as diagnostic musculoskeletal ultrasound and patient access…

    Providers Using RISE Have Advantage with 2017 MIPS Reporting

    March 15, 2018

    Hundreds of rheumatology providers across the country are finalizing submissions for the first year of reporting under the Merit-Based Incentive Payment System (MIPS). According to a presentation at the 2017 ACR/ARHP Annual Meeting in San Diego, providers that participate in and submit through the Rheumatology Informatics System for Effectiveness (RISE) Registry are poised to perform…

    Medicare Access and CHIP Reauthorization Act of 2015: What You Should Know

    April 15, 2016

    There is no denying that the past few years have been a time of immense change in healthcare. Sweeping pieces of legislation have fundamentally altered the way we practice medicine. This is absolutely the case when it comes to the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA, for short). MACRA is an enormous…

    RISE Registry Helps ACR Members Successfully Navigate MIPS

    April 26, 2018

    Time certainly flies, and 2018 marks the second year that rheumatologists who see Medicare patients are operating under the new Quality Payment Program (QPP) created by the Medicare Access & CHIP Reauthorization Act (MACRA). MACRA repealed the Fee-for-Service model under the Sustainable Growth Rate (SGR) formula and transitioned Medicare reimbursement to a system more overtly…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences